If you are:
FDB Contraindicated or Not Recommended: NO FDA CATEGORY; NOT RECOMMENDED ESPECIALLY IN 3RD TRIMESTER OR NEAR TERM
FDB Contraindicated or Not Recommended: SALICYLATES NOT RECOMMENDED ESPECIALLY IN 3RD TRIMESTER/NEAR TERM
Only When Necessary: REPORTS OF MISCARRIAGE,POOR FETAL GROWTH POSSIBLY ASSOC W/HIGH DOSES OF CAFFEINE
Absolute Contraindication: ONE REPORT OF METABOL ACIDOSIS W/ASA;RISK OF REYE'S SYN W/VIRAL ILLNESS/FEVER
Precaution: HIGH DOSES MAY CAUSE HYPERACTIVITY AND WAKEFULNESS IN INFANT.
Absolute Contraindication: ONE REPORT OF METABOLIC ACIDOSIS; RISK OF REYE'S SYND IN VIRAL ILLNESS.
An adult over 60:
management or monitoring precaution: Neuro/Psych-Avoid in elderly with insomnia due to CNS stimulation effects.
management or monitoring precaution: Gastrointestinal-Aspirin doses > 325 mg/day carry an increased risk for hemorrhage, GI bleed and ulceration. Lower doses preferred.
management or monitoring precaution: General-Elderly have a higher incidence of systemic toxicities. Dose reduction may be needed.
Giving Arthritis Strength BC Powder 742 mg-222 mg-36 mg oral packet to a child under 12:
management or monitoring precaution: Adverse CNS effects of insomnia, restlessness, nervousness, and mild delirium, more severe in children.
Severe Precaution: Reye syndrome risk with viral illness, fever, and/or flu symptoms.
Severe Precaution: Do not use in viral illness due to possible increase risk of Reye syndrome.
management or monitoring precaution: Caution in: seizure disorder, cardiovascular disease, or in premature neonates with renal or hepatic impairment.